Embracing Future Holdings Limited Stock Price
Last Done:
SGD 9.39
+0.12 (+1.31%)
• Login required for live price
Open: --
High: --
Low: --
Prev Close: --
Login to unlock live stock price, change %, and intraday data.
Login to View
📊 Statistics
- Analyst 1 Year Price Target:
-
- Upside/Downside from Analyst Target:
-
- Broker Call:
-
- Dividend Minimum 3 Year Yield:
0.00%
- EPS Growth Range (1Y):
25-50%
- Net Income Growth Range (1Y):
<0%
- Revenue Growth Range (1Y):
>500%
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 SGX Earnings Announcements for 8YY
Embracing Future Holdings Limited (8YY)
Market: SGX |
Currency: SGD
Address: 18 Howard Road
Embracing Future Holdings Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions in Japan, Hong Kong, Thailand, Malaysia, and the United States. It operates through Cancer, Infectious Diseases, and Laboratory Services segments. The company offers ClearCell FX1 System that includes Streck Cell-free DNA BCT and EDTA tubes, a fully automated device for cell retrieval that can separate wholly intact and viable circulating tumour cells, or CTCs from small amounts of blood; and CTChip FR1 biochip that isolate the CTCs from leukocytes. It also provides laboratory services. The company was formerly known as Biolidics Limited and changed its name to Embracing Future Holdings Limited in June 2025. The company was incorporated in 2009 and is based in Singapore.
Show more
📈 Embracing Future Holdings Limited Historical Chart
🧾 Recent Financial Statement / Corporate annoucement / News
March 16, 2026
Embracing Future Holdings Limited - Major Acquisition and Share Issuance Announcement Embracing Future Holdings Limited Announces Major Acquisitions and Significant Share Issuances Key Highlights from the Latest Corporate Announcement Major Acquisitions: Embracing Future Holdings Limited ("the Company") has announced updates…
March 2, 2026
Embracing Future Holdings Limited – Key Updates on Proposed Acquisition Transactions and Whitewash Waiver Embracing Future Holdings Limited – Detailed Update on Proposed Acquisitions and Whitewash Waiver Date: 2 March 2026 Company: Embracing Future Holdings Limited Executive Director & Chairman:…
January 20, 2026
Embracing Future Holdings Responds to SGX Queries on Major Acquisitions Embracing Future Holdings Responds to SGX Queries on Major Acquisitions Embracing Future Holdings Limited (the "Company") has issued a comprehensive response to the Singapore Exchange Securities Trading Limited’s (SGX-ST) queries…
December 8, 2025
Embracing Future Holdings Limited: Achievement of NPAT Target and Release of Earn-Out Consideration Shares Embracing Future Holdings Limited Announces Major Milestone in Shenzhen Xiaozhao Acquisition Key Highlights NPAT Target Substantially Exceeded: Shenzhen Xiaozhao Network Technology Co., Ltd, now an indirect…
August 26, 2025
Embracing Future Holdings Expands into Hong Kong Esports Market with New Subsidiary: What Investors Should Know Key Points at a Glance Embracing Future Holdings Limited (formerly Biolidics Limited) has incorporated a wholly owned subsidiary in Hong Kong. The new entity,…
August 12, 2025
Embracing Future Holdings Limited: HY FY2025 Financial Analysis Embracing Future Holdings Limited (formerly Biolidics Limited) has released its unaudited interim financial statements for the six months ended 30 June 2025. The company, recently pivoting from biomedical technology to focus on…
🔎 View more in SGX corporate News 🔎 View more in SGX Financial statements
📰 Research Reports
usort($results_posts, function($a, $b) {
return get_post_time('U', true, $b) - get_post_time('U', true, $a);
});
?>
No related articles found.
